Literature DB >> 10775221

Worsening of symptoms of multiple sclerosis associated with carbamazepine.

G Ramsaransing1, C Zwanikken, J De Keyser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10775221      PMCID： PMC27354     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors:  Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

Review 2.  Pharmacological management of pain in patients with multiple sclerosis.

Authors:  Claudio Solaro; Michele Messmer Uccelli
Journal:  Drugs       Date:  2010-07-09       Impact factor: 9.546

Review 3.  Management of pain in multiple sclerosis: a pharmacological approach.

Authors:  Claudio Solaro; Michele Messmer Uccelli
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

Review 4.  Pain and multiple sclerosis: pathophysiology and treatment.

Authors:  Claudio Solaro; Erika Trabucco; Michele Messmer Uccelli
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

Review 5.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Oral administration of PF-01247324, a subtype-selective Nav1.8 blocker, reverses cerebellar deficits in a mouse model of multiple sclerosis.

Authors:  Shannon D Shields; Richard P Butt; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

Review 7.  Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia.

Authors:  G Di Stefano; A Truini; G Cruccu
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.